Magnesium and outcomes in patients with chronic kidney disease: Focus on vascular calcification, atherosclerosis and survival

CKJ: Clinical Kidney Journal

Volumn 5, Issue SUPPL. 1, 2012, Pages

  Massy, Ziad A ^a,b   Drüeke, Tilman B ^b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

atherosclerosis; chronic kidney disease; magnesium; survival; vascular calcification

Indexed keywords

CALCIUM ACETATE; CALCIUM ANTAGONIST; MAGNESIUM; MAGNESIUM CARBONATE; MAGNESIUM CITRATE;

ARTERIAL WALL THICKNESS; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; DIET SUPPLEMENTATION; DISEASE MODEL; FATALITY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IN VITRO STUDY; KIDNEY FAILURE; MAGNESIUM BLOOD LEVEL; MORBIDITY; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; SURVIVAL;

EID: 84864445208     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ndtplus/sfr167     Document Type: Article

References (79)

1. Foley RN, Parfrey PS. Cardiovascular disease and mortality in ESRD. J Nephrol 1998; 11: 239-245
2. Braun J, Oldendorf M, Moshage W et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996; 27: 394-401
3. Blacher J, Demuth K, Guerin AP et al. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 1998; 18: 535-541
4. Speer MY, Giachelli CM. Regulation of cardiovascular calcification. Cardiovasc Pathol 2004; 13: 63-70
5. Nakamura S, Ishibashi-Ueda H, Niizuma S et al. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol 2009; 4: 1892-1900
6. London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740
7. Noordzij M, Cranenburg EM, Engelsman LF et al. Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant 2011; 26: 1662-1669
8. Cheung AK, Sarnak MJ, Yan G et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353-362
9. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004; 95: 560-567
10. Ivanovski O, Szumilak D, Nguyen-Khoa T et al. The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice. Kidney Int 2005; 67: 2288-2294
11. Moe S, Drueke T, Cunningham J et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69: 1945-1953
12. Shroff RC, McNair R, Figg N et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008; 118: 1748-1757
13. Temmar M, Liabeuf S, Renard C et al. Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J Hypertens 2010; 28: 163-169
14. Shroff RC, McNair R, Skepper JN et al. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellularmatrix calcification. J Am Soc Nephrol 2010; 21: 103-112
15. El-Abbadi M, Giachelli CM. Mechanisms of vascular calcification. Adv Chronic Kidney Dis 2007; 14: 54-66
16. Nikolov IG, Mozar A, Drueke TB et al. Impact of disturbances of calcium and phosphate metabolism on vascular calcification and clinical outcomes in patients with chronic kidney disease. Blood Purif 2009; 27: 350-359
17. Schoppet M, Shroff RC, Hofbauer LC et al. Exploring the biology of vascular calcification in chronic kidney disease: What's circulating? Kidney Int 2008; 73: 384-390
18. Shanahan CM. Mechanisms of vascular calcification in renal disease. Clin Nephrol 2005; 63: 146-157
19. Moe SM, Drueke T, Lameire N et al. Chronic kidney diseasemineral- bone disorder: A new paradigm. Adv Chronic Kidney Dis 2004; 14: 3-12
20. Giachelli CM, Jono S, Shioi A et al. Vascular calcification and inorganic phosphate. Am J Kidney Dis 2001; 38: S34-S37
21. Jahnen-Dechent W, Schafer C, Ketteler M et al. Mineral chaperones: A role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med 2008; 86: 379-389
22. O'Neill WC, Lomashvili KA. Recent progress in the treatment of vascular calcification. Kidney Int 2010; 78: 1232-1239
23. Rennenberg RJ, Schurgers LJ, Kroon AA et al. Arterial calcifications. J Cell Mol Med 2010; 14: 2203-2210
24. Riser BL, Barreto FC, Rezg R et al. Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia. Nephrol Dial Transplant 2011; 26: 3349-3357
25. Sage AP, Lu J, Tintut Y et al. Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 2011; 79: 414-422
26. Villa-Bellosta R, Millan A, Sorribas V. Role of calcium-phosphate deposition in vascular smooth muscle cell calcification. Am J Physiol Cell Physiol 2011; 300: C210-C220
27. Schlieper G, Aretz A, Verberckmoes SC et al. Ultrastructural analysis of vascular calcifications in uremia. J Am Soc Nephrol 2010; 21: 689-696
28. Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004; 15: 2959-2964
29. Sun Y, Zeng XR, Wenger L et al. Basic calcium phosphate crystals stimulate the endocytotic activity of cells-inhibition by anti-calcification agents. Biochem Biophys Res Commun 2003; 312: 1053-1059
30. Jono S, McKee MD, Murry CE et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-E17
31. Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 2006; 98: 905-912
32. Reynolds JL, Joannides AJ, Skepper JN et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15: 2857-2867
33. Ewence AE, Bootman M, Roderick HL et al. Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: A potential mechanism in atherosclerotic plaque destabilization. Circ Res 2008; 103: E28-e34
34. Son BK, Kozaki K, Iijima K et al. Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway. Circ Res 2006; 98: 1024-1031
35. Proudfoot D, Skepper JN, Hegyi L et al. Apoptosis regulates human vascular calcification in vitro: Evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000; 87: 1055-1062
36. LeGeros RZ. Formation and transformation of calcium phosphates: Relevance to vascular calcification. Z Kardiol 2001; 90: III/116-III/124
37. Cheng PT, Grabher JJ, LeGeros RZ. Effects of magnesium on calcium phosphate formation. Magnesium 1988; 7: 123-132
38. Peters F, Epple M. Simulating arterial wall calcification in vitro: Biomimetic crystallization of calcium phosphates under controlled conditions. Z Kardiol 2001; 90 (Suppl 3): 81-85
39. Altura BM, Altura BT, Carella A et al. Mg21-Ca21 interaction in contractility of vascular smooth muscle: Mg21 versus organic calcium channel blockers on myogenic tone and agonistinduced responsiveness of blood vessels. Can J Physiol Pharmacol 1987; 65: 729-745
40. Montezano AC, Zimmerman D, Yusuf H et al. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension 2010; 56: 453-462
41. Kircelli F, Peter ME, Sevinc OE et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dosedependent manner. Nephrol Dial Transplant 2011. doi: 10.1093/ndt/gfr321
42. Brown EM, Gamba G, Riccardi D et al. Cloning and characterization of an extracellular Ca(21)-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-580
43. Ivanovski O, Nikolov IG, Joki N et al. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice. Atherosclerosis 2009; 205: 55-62
44. Verberckmoes SC, Persy V, Behets GJ et al. Uremia-related vascular calcification: More than apatite deposition. Kidney Int 2007; 71: 298-303
45. Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J 2012; 5 (Suppl 1): I3-i14
46. Contiguglia SR, Alfrey AC, Miller NL et al. Nature of soft tissue calcification in uremia. Kidney Int 1973; 4: 229-235
47. LeGeros RZ, Contiguglia SR, Alfrey AC. Pathological calcifications associated with uremia: Two types of calcium phosphate deposits. Calcif Tissue Res 1973; 13: 173-185
48. Boskey AL, Posner AS. Effect of magnesium on lipid-induced calcification: An in vitro model for bone mineralization. Calcif Tissue Int 1980; 32: 139-143
49. Termine JD, Peckauskas RA, Posner AS. Calcium phosphate formation in vitro. II. Effects of environment on amorphouscrystalline transformation. Arch Biochem Biophys 1970; 140: 318-325
50. Bennett RM, Lehr JR, McCarty DJ. Factors affecting the solubility of calcium pyrophosphate dihydrate crystals. J Clin Invest 1975; 56: 1571-1579
51. Brown EM. Extracellular Ca21 sensing, regulation of parathyroid cell function, and role of Ca21 and other ions as extracellular (first) messengers. Physiol Rev 1991; 71: 371-411
52. Smajilovic S, Hansen JL, Christoffersen TE et al. Extracellular calcium sensing in rat aortic vascular smooth muscle cells. Biochem Biophys Res Commun 2006; 348: 1215-1223
53. Gorgels TG,Waarsing JH, deWA et al. Dietary magnesium, not calcium, prevents vascular calcification in a mouse model for pseudoxanthoma elasticum. J Mol Med 2010; 88: 467-475
54. Schwille PO, Schmiedl A, Schwille R et al. Media calcification, low erythrocyte magnesium, altered plasma magnesium, and calciumhomeostasis following grafting of the thoracic aorta to the infrarenal aorta in the rat-differential preventive effects of long-termoralmagnesiumsupplementation alone and in combination with alkali. Biomed Pharmacother 2003; 57: 88-97
55. van den Broek FA, Beynen AC. The influence of dietary phosphorus and magnesium concentrations on the calcium content of heart and kidneys of DBA/2 and NMRI mice. Lab Anim 1998; 32: 483-491
56. Ishimura E, Okuno S, Kitatani K et al. Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin Nephrol 2007; 68: 222-227
57. Li Q, Larusso J, Grand-Pierre AE et al. Magnesium carbonatecontaining phosphate binder prevents connective tissue mineralization in Abcc6(-/-) mice - potential for treatment of pseudoxanthoma elasticum. Clin Transl Sci 2009; 2: 398-404
58. Iseri LT, French JH. Magnesium: Nature's physiologic calcium blocker. Am Heart J 1984; 108: 188-193
59. Meema HE, Oreopoulos DG, Rapoport A. Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int 1987; 32: 388-394
60. Tzanakis I, Pras A, Kounali D et al. Mitral annular calcifications in haemodialysis patients: A possible protective role of magnesium. Nephrol Dial Transplant 1997; 12: 2036-2037
61. Mazzaferro S, Coen G, Bandini S et al. Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus. Nephrol Dial Transplant 1993; 8: 335-340
62. Tzanakis I, Virvidakis K, Tsomi A et al. Intra- and extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes Res 2004; 17: 102-108
63. Hashimoto T, Hara A, Ohkubo T et al. Serum magnesium, ambulatory blood pressure, and carotid artery alteration: The Ohasama study. Am J Hypertens 2010; 23: 1292-1298
64. Geiger H,Wanner C. Magnesium in disease. Clin Kidney J 2012; 5 (Suppl 1): I25-i38
65. Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 1998; 136: 480-490
66. Ma J, Folsom AR, Melnick SL et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995; 48: 927-940
67. O'Leary DH, Polak JF, Kronmal RA et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22
68. Altura BM, Altura BT. Magnesium and cardiovascular biology: An important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res 1995; 41: 347-359
69. Izawa H, Imura M, Kuroda M et al. Proceedings: Effect of magnesium on secondary hyperparathyroidism in chronic hemodialysis: A case with soft tissue calcification improved by high Mg dialysate. Calcif Tissue Res 1974; 15: 162
70. Spiegel DM, Farmer B, Smits G et al. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: A pilot study. J Ren Nutr 2007; 17: 416-422
71. Spiegel DM, Farmer B. Long-term effects of magnesium carbonate on coronary artery calcification and bone mineral density in hemodialysis patients: A pilot study. Hemodial Int 2009; 13: 453-459
72. Qunibi W, Moustafa M, Muenz LR et al. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis 2008; 51: 952-965
73. Block GA, Spiegel DM, Ehrlich J et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005; 68: 1815-1824
74. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252
75. Turgut F, Kanbay M, Metin MR et al. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol 2008; 40: 1075-1082
76. Ishimura E, Okuno S, Yamakawa T et al. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res 2007; 20: 237-244
77. Passlick-Deetjen J, Wang Wet al. Magnesium and mortality risk in hemodialysis patients. European Renal Association (ERA) and European Dialysis and Transplant Association (EDTA), XLVII Congress, 25-28 June, Munich, Germany. Oral presentation
78. Lacson E, Wang W, Lazarus M et al. Magnesium and mortality risk in hemodialysis patients. American Society of Nephrology, 42nd Annual Meeting & Scientific Exposition (Renal Week), 27 October-1 November, San Diego, CA, USA. 2009 Poster F-PO1488
79. Marzell B, Arkossy O et al. Association of serum magnesium with mortality-results from a large European database. ERA-EDTA Congress, Prague, 26 June 2011. Abstract SuO008